There’s nothing worse than a dim kitchen when you’re trying to cook. Not only is it hard to see your ingredients or read a recipe, it can make slicing and dicing downright dangerous. Still, some homes and apartments weren’t constructed with cooking in mind. There’s an easy fix for a dark kitchen, though, and it’s hiding at Target — meet Threshold’s Mini Rattan Wrap Stick Table Lamp.
Target
This compact lamp is well-suited to smaller nooks and crannies, like under kitchen cabinets.
This petite lamp measures 14 inches by 6.5 inches, and it works just as easily in the kitchen as it does on a bedside table. Small enough to fit into tight corners and underneath cabinets, its details still make it feel slightly elevated. From its brass-colored base and pull switch to its rattan-covered post, it looks like it should cost you way more than $12.
Whether you pop it on top of your cookbooks or behind your salt and pepper shakers, this light gives off a great glow (that also won’t be too bright while you’re cooking). Flick it on and forgo your overhead light at night or in the morning, and set a cozy mood for a quick snack or breakfast. It weighs just over a pound and has a 5-foot cord, so you can move it around as needed without much effort.
This lamp is a quick, easy way to add a little warmth to a room without splurging. (Target)
One happy shopper called it the “perfect little lamp” and shared: “Bought these when they were $12 each. Have them all around my apartment. Love them. Very warm and classy looking.”
Another five-star fan declared the lamp “one of my favorite pieces.” The reviewer uses it “in my kitchen for some warmer light, and it is adorable.”
A savvy customer explained: “I bought this [lamp] and use a battery-powered screw in-base bulb, with a tiny remote. If you use it this way, you can move it anywhere in your house. The lamp is neutral and goes with anything. I also have two other mini lamps from Target and they are used everywhere. One is in my kitchen, one in the family room and this new one also in the family room. Nice, subtle light.”
“Cutest mini lamp at a great price point,” said a final shopper. “I placed this in a nook in my kitchen. The only downside in my opinion is the black cord is not attractive and [I’m] finding it hard to hide.”
Target
The brass and rattan details are neutral and classy enough for just about any setting.
MELBOURNE, Australia, March 13, 2024 /PRNewswire/ — Datos Health, a global leader in remote care automation, announced today the company’s Open Care platform, was chosen by Northern Health, a major Australian healthcare provider. Northern Health has partnered with Datos Health to develop innovative digital care models to enable a healthier community by improving the health outcomes that matter most to patients. This includes being able to deliver the right care, at the right time, in the right place, by utilising remote patient monitoring.
Datos Health’s Open Care platform replaces rigid RPM solutions with a comprehensive platform for hybrid care delivery. The company’s streamlined solution empowers healthcare organisations like Northern Health to customise remote care protocols to fit their unique approach to healthcare. Clinicians can easily adjust workflows as needed, with changes instantly translated into patient CareApps that deliver automated assisted self-care.
Northern Health will integrate the Open Care platform into its virtual cardiac rehabilitation, back pain, lung cancer, severe asthma and gestational diabetes programs with plans to expand Datos into other programs to support their community’s healthcare needs into the future.
Datos Health will leverage IKAO Health, its Australian-based partner for their experience implementing localised solutions to meet the unique issues facing healthcare providers and to deliver on-the-ground support and service to Northern Health.
Northern Health is committed to delivering safe, person-centred and value-based care by redesigning models of care to improve patient outcomes, automating clinical workflows to reduce administrative burden for clinicians and enhancing greater access to care for patients. The Datos platform offers exceptional flexibility and a seamless user experience for both patients and clinicians. Moreover, its ability to provide real-time data visualisations, ensures that clinicians can tailor and personalise care plans. Northern Health is dedicated to advancing health equity within its diverse community, empowering patients to better self-manage their health, monitor and track their progress over time, and access trusted educational resources.
“Northern Health is creating a future where virtual care models enable a healthier community,” said Dr. Katharine See, Chief Health Outcomes Officer and Director of Respiratory Medicine at Northern Health. “We’re a pioneer in implementing digital health solutions that cater to the changing needs of our community. With Datos Health, we’re enabling our healthcare professionals to offer exceptional virtual care options, that are not dependent on patients being in hospital. We look forward to working with Datos Health to roll out even more innovative digital health programs that support our community,” she continued.
“We’re honoured to have been chosen by such a respected healthcare organisation and we look forward to working with Northern Health to design new and innovative care models,” said Uri Bettesh, Founder and CEO of Datos Health. “Together with our local partner, IKAO Health, we’ve developed an excellent grasp of the intricacies of the Australian healthcare system. Our partnership with Northern Health is an excellent next step on our road to increasing access to care for Australia’s highly diverse patient population, and our continuing expansion in the Asia-Pacific region,” he concluded.
About Northern Health Northern Health is a major provider of comprehensive health services in Melbourne’s rapidly growing outer north, catering to a vibrant community of diverse backgrounds. Across five main campuses, Northern Health delivers acute, maternity, sub-acute, mental health, specialist, community and home-based services. Handling over 110,000 emergency cases annually and supporting 114,000 admissions, their commitment extends to ensuring accessible care for all, irrespective of language or culture. With over 8,500 dedicated professionals, they are committed to providing exceptional healthcare tailored to each individual, promoting well-being across Melbourne’s dynamic northern landscape. For more information, please visit www.nh.org.au.
About Datos Health Datos Health’s open platform merges monitoring, care, and engagement, to seamlessly deliver hybrid care across any acuity level or use case. Clinicians can quickly implement and customize any program, choose the devices that fit their workflow, and integrate with any EMR. Workflows can easily be adjusted in our Design Studio by creating remote care programs from scratch or by leveraging existing protocols from leading healthcare organizations. These workflows are instantly translated into patient CareApps that collect biometrics and PROMs, provide self-care guidance and curated content, send escalation alerts to the care team, and facilitate virtual visits. Workflow automation is now easier than ever for both patients and clinicians. For more information, please visit www.datos-health.com.
BEIJING, March 12, 2024 /PRNewswire/ — On March 12, the iQIYI original Chinese series To the Wonder was announced by the CANNESERIES (The Cannes International Series Festival), as part of this year’s Official Selection for Long Form Competition. This marks the first Chinese language long-form drama series to be selected in this competition since its launch in 2018. To the Wonder is set for its world premiere in Cannes on April 7, where it will vie for five major awards against seven other international series.
The nominated mini-series is an adaptation of the award-winning essay collection My Altay by Juan LI, a renowned Chinese essayist. Set in Xinjiang’s pristine Altay region, the 8-episode series offers a fresh narrative and sensory experience, blending light comedy with Li’s literary aesthetics to explore themes of nature reverence, self-discovery, and the simple yet resilient spirit of the northern Xinjiang herders.
Produced by iQIYI, co-produced by RUYI FILM and THE CITY FILM, the series boasts a top-notch cast and production team, which includes some of the acclaimed actors such as Yili MA, winner of the Best Actress award at the 2018 Shanghai Magnolia Awards, one of the most prestigious television awards in China, Yiran ZHOU and Shi YU in the lead roles, with special appearances by Qiming JIANG and Peilun YAN. Other main cast members include Xiaojuan HUANG, Alimujiang TULUXUNBAIKE, Alima, and Hailati HAMU.
The production team includes executive producer Dapeng, director Congcong TENG, scriptwriter Yining PENG, chief producer Kang QI and Yueting CAI, producer Shuo ZHANG, cinematography director Yizeng LIU, art director Jianing LI, styling director Yige ZHAO, sound recording director Nan ZHANG, editing director Xinxia ZHOU, and composer Xiaoyang GAO, among others.
Reflecting on the universal themes of the series, director Teng remarked, “Art and love enable humanity to transcend language and national boundaries. “
Kang QI, one of the chief producers of the series and head of iQIYI’s Canran Studio further emphasized the collaborative nature of the project, stating, “We are very fortunate to explore uncharted territories with our outstanding collaborators.”
CANNESERIES, now in its 7th year and scheduled to take place from April 5 to 10, continues its commitment to showcasing international talents, celebrated screenwriters, and contributors from the multifaceted world of television series production. The selection of To the Wonder for the festival places it alongside notable past selections such as BBC America’s Killing Eve, the German period drama series Bauhaus: A New Era, the French biographical mini-series Tapie, and the gripping South Korean thriller, Bargain.
The selection of To the Wonder for CANNESERIES marks another milestone in the global recognition of Chinese language dramas, following the earlier selection of another iQIYI original Chinese series, Why Try to Change Me Now, which was selected for the Berlinale Series selection of the 73rd Berlin International Film Festival. These achievements highlight iQIYI’s dedication to creating high-quality content that resonates with global audiences and underscore its growing influence in the international entertainment industry.
Show Information: To the Wonder Genre: Drama Format: 45 minutes x 8 episodes Creators: Yu GONG, Xiaohui WANG Executive Producer: Dapeng (One and Only, The Reunions) Director and Screenwriter: Congcong TENG (Send Me to the Clouds) Original Author: Juan LI Screenwriters: Congcong TENG, Yining PENG Chief Producer: Kang QI, Yueting CAI Producer: Shuo ZHANG, Man WANG Presented and Produced by: BEIJING IQIYI SCIENCE AND TECHNOLOGY CO., LTD. Co-produced by: SHANGHAI RUYI FILM&TV PRODUCTION CO., LTD. THE CITY FILM CO., LTD.
SHANGHAI, March 12, 2024 /PRNewswire/ — AWE2024, a top tech event of the global household appliances and consumer electronics industry, is set to kick off at Shanghai New International Expo Center on March 14 under the theme of Smartize the Future. With 13 exhibition halls, AWE2024 will attract over a thousand leading industry players. As a top three global exhibition of the industry, AWE2024 will witness nearly 100 events from exhibitors to unveil their new products, technologies and strategies.
Photo from AWE2023
Photo from AWE2023
AWE2024 will showcase the integration of cutting-edge technologies such as AI with the industry, especially innovations made in smart home scenarios and technology-powered ecosystems. Haier Smart Home, along with brands under its umbrella including Haier, Casarte, Leader, GE APPLIANCES, Fisher & Paykel, and Sanyiniao, will again cover an entire hall. Huawei will present its whole scenario technology products and interconnected future home experience. Hisense will showcase its news laser televisions, displays and its deployment in chips, automotive electronics, VR, and energy solutions. TCL will display over 150 types of state-of-the-art tech products across 37 categories. Bosch will showcase its innovative green smart home appliances. Siemens will bring an entire range of smart home appliances. Panasonic will debut Panasonic Xtra, a sub-brand targeting Generation Z. Samsung will exhibit its industry-beating mobile phones, televisions, home appliances, and gaming monitors. LG will present its portable televisions, OLED gaming monitors, and steam clothing care machines. Gree will showcase its solar (wind) power, energy storage, central air conditioning, floor heating and outdoor air systems.
AWE2024 will host two top summits centering on sustainability and smart home respectively. It will also provide great exposure to new products and highlights of exhibitors through the coverage from more than 100 media outlets and more than 1,000 onsite live streams.
Considering AWE’s expanding global influence, Samsung will bring its whole line of products including mobile phones to AWE for the first time. A. O. Smith will return. Hitachi Air Conditioning will join in the name of its Japanese headquarter. BSH, LG and Samsung will bring their global executive teams to AWE. Local heavyweights such as Haier, Hisense, and TCL will invite their global clients.
Jiang Feng, Executive President of the China Household Electrical Appliances Association, noted that AWE intends to collaborate with global partners to promote technological innovation and high-quality sustainable development of the industry to provide global consumers a smart, healthy, comfortable and green life.
This month marks the four-year anniversary of the beginning of the COVID-19 pandemic in the U.S. During the months on lockdown, millions of Americans were grappling with uncertainty, with worries ranging from becoming ill and being separated from loved ones to facing unemployment — while simultaneously helping kids with virtual learning, sanitizing the groceries and searching high and low for a package of toilet paper. Even though the days of social distancing are behind us, some of the impacts of the pandemic — both positive and negative — have been long-term. Here, mental health professionals break down some of the important lessons we’ve learned since 2020.
Lesson No. 1: Loneliness is detrimental to our health
The pandemic both exacerbated and shined a spotlight on how many Americans were struggling with loneliness — defined by the Centers for Disease Control and Prevention as feeling isolated and “like you do not have meaningful or close relationships or a sense of belonging.” In a 2023 report, the U.S. surgeon general shared that 10 years ago, he didn’t view loneliness as a public health problem, but learned through research that being socially disconnected is harmful — its impact on mortality being equivalent to “smoking up to 15 cigarettes a day.” Loneliness is linked to a higher risk of cardiovascular disease, stroke, dementia, depression, anxiety and premature death, according to the report. This led to the surgeon general declaring the epidemic of loneliness a “public health crisis” in 2023.
Those feelings of loneliness still persist. Peggy DeLong, psychologist and author of Feeling Good: Thirty-Five Proven Ways to Happiness, Even During Tough Times, refers toa 2024 poll conducted by the American Psychiatric Association, which revealed that 30% of adults reported feeling lonely once every week, 30% of younger people ages 18 to 34 reported feeling lonely every day or several times a week and 25% of adults said that they were feeling lonelier than before the pandemic.
But there are things that can help. DeLong tells Yahoo Life that one possible solution is to reach out to old friends and let them know you’re thinking about them. “Put a date on the calendar to get together, and don’t let the awkwardness associated with the passage of time make you think that they don’t want to hear from you,” she says. “In fact, research indicates that the surprise factor makes it an even more pleasant experience for the recipient.”
She also recommends participating in local nonprofit organizations, attending events at the local library or chatting with someone you don’t know, such as the cashier at the grocery store or a customer standing behind you in line. “Connecting with strangers makes us feel seen and connected to our communities and the world,” says DeLong.
Lesson No. 2: We’re talking more about our emotional well-being and seeking support
The social isolation — and ensuing loneliness — that many struggled with earlier in the pandemic in an effort to prevent the spread of COVID-19 brought conversations about mental health to the forefront and led to a slew of people seeking mental health support. A 2022 survey by the American Psychological Association found that most psychologists saw an increase in patients needing help for anxiety, depression or stress in 2020, as well as in 2021 and 2022.
A CDC report backs that up, finding that the percentage of adults who had received mental health treatment — namely, therapy with a mental health professional, a prescription medication for mental health or both — increased from 19.2% in 2019 to 21.6% in 2021. Focusing on well-being continues to be a priority for many. A poll conducted by the American Psychiatric Association found that 28% of Americans planned on heading into 2024 with the goal of continuing to improve their mental health.
The stigma of mental health issues has also been slowly declining, notes Elizabeth Lombardo, clinical psychologist and author of Get Out of the Red Zone: Transform Your Stress and Optimize True Success. “First and foremost, I believe people are learning about the importance of mental health,” she tells Yahoo Life. “Whether they are taking more steps to improve their mental health or have become aware that it would be helpful for them to take these steps, I think people are realizing the pivotal role it plays in our well-being.”
Lesson No. 3: Telemedicine works and is here to stay
Think of it as the modern-day house call. Because of the pandemic, having a virtual session with a health care provider has been on the rise over the last 48 months. A 2023 American Medical Association survey found that more than 74% of physicians reported using telehealth in their practices — “nearly three times the share in 2018.” The report also noted that while only 14.3% of doctors were communicating with their patients via telehealth in 2018, that jumped to more than 66% of physicians in 2022. Although COVID-19 is no longer considered a public health emergency, study authors of a 2022 paper stated that “telemedicine will remain a permanent fixture in routine American health care.”
Lombardo says that’s a good thing. “Telemedicine is good for physical and mental health,” she says. “We’ve realized that taking care of our well-being doesn’t have to look the way it used to look.”
Lesson No. 4: We learned that masks are effective
Several studies have come out during the pandemic showing the effectiveness of face masks in reducing the spread of airborne pathogens, including SARS-CoV-2 — the virus that causes COVID-19. A 2021 JAMA study points out that there’s “compelling” research that “community mask wearing is an effective nonpharmacologic intervention to reduce the spread of this infection, especially as source control to prevent spread from infected persons, but also as protection to reduce wearers’ exposure to infection.”
A 2022 study in the Journal of Infectious Diseases found that face masks shorten the distance that airborne pathogens can travel when people cough or talk by more than half compared to not wearing a mask.
Lesson No. 5: We’re pursuing more hobbies
“Before the pandemic, having a hobby was seen as a luxury,” says Lombardo. “But once we had all this time at home, people started spending time doing something creative,” whether that was baking, knitting, hiking or gardening. Four years into the pandemic, many are still engaging in leisurely activities. A 2023 Gallup poll showed that hobbies are considered an important aspect of life among 61% of American adults — a 13% increase compared to those surveyed in 2002.
That’s a good thing since research shows an association between having hobbies and healthy aging. In a 2023 observational study of more than 93,000 people across 16 countries, researchers noted that hobbies tend to involve creativity, sensory engagement, self-expression, relaxation and cognitive stimulation — factors that have been linked to positive mental health and improved well-being.
Hobbies can include “learning something new or doing something creative, like baking, taking music lessons or doing a home project,” says Lombardo. Cooking, a hobby that also provides a health benefit, was one of the most positive outcomes from the pandemic, according to the World Health Organization. A 2021 survey of 1,000 Americans aged 18 and older found that about 44% reported cooking more often since pandemic began, while 31% said they started trying new recipes.
Lesson No. 6: We’re practicing better hygiene
Remember all the news segments on proper handwashing early in the pandemic, including singing “Happy Birthday” to make sure people were washing their hands for long enough? It looks like those demonstrations paid off. According to a 2024 Healthy Handwashing survey by Bradley Company, 74% of American adults wash their hands more frequently (or more thoroughly) in response to seasonal virus outbreaks, while 54% increase their handwashing activity when they’re sick.
Although a 2023 study did find a link between SARS-CoV-2 on people’s hands and frequently touched household surfaces and infection, COVID-19 is much more likely to spread through respiratory droplets released into the air when people talk or cough. But experts say that regular handwashing with soap and water for at least 20 seconds is still important. That’s because it’s a highly effective way to avoid getting sick from respiratory infections in general, including cold and flu, as well as diarrheal illnesses like norovirus, according to the CDC. It’s why the New York Times called handwashing “the pandemic habit we should not break.”
MELBOURNE, Australia, March 12, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce the appointment of Dr. Darren Patti as Group Chief Operating Officer (COO), effective 11 March 2024.
Dr. Patti joined Telix in March 2021 to lead the Company’s United States (U.S.) operations. Over the past three years as U.S. Chief Operating Officer and General Manager for the Americas region he has overseen the successful launches of Illuccix® in the U.S. and Canada, has led ongoing market development for Telix in Brazil and the Latin America (LATAM) region, and has been a key figure in the launch preparations for Telix’s follow-on imaging products Zircaix®[1] and Pixclara™[1] (subject to regulatory approval). Prior to joining Telix, Darren held a variety of roles at Sofie Biosciences over a period of 15 years, most recently as Vice President of Operations leading the operationalisation of the Sofie-Lantheus PSMA-PET imaging program.
Darren holds a Doctor of Pharmacy (Pharm.D.) from the University of Illinois at Chicago and is an Authorised Nuclear Pharmacist.
Dr. Christian Behrenbruch, Managing Director and Group CEO commented, “Darren has been an exemplary leader in our Americas region and fundamental to the success of our commercial operations and vertical integration strategy. Darren’s deep experience in radiopharmacy network management and operations, combined with an intricate understanding of the Telix business makes him the ideal leader for our global operations function as we expand into new commercial markets and bolster our manufacturing capabilities to support our therapeutic and imaging programs. I am looking forward to continuing to work closely with Darren in this new role as we prepare to bring additional diagnostic products to market and drive towards our next phase as a leader in therapeutic radiopharmaceuticals and precision medicine.”
About Telix Pharmaceuticals Limited
Telix is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals and associated medical devices. Telix is headquartered in Melbourne, Australia, with international operations in the United States, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX).
Visit www.telixpharma.com for further information about Telix, including details of the latest share price, announcements made to the ASX, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on X and LinkedIn.
Telix’s lead imaging product, gallium-68 (68Ga) gozetotide injection (also known as 68Ga PSMA-11 and marketed under the brand name Illuccix®), has been approved by the U.S. Food and Drug Administration (FDA),[2] by the Australian Therapeutic Goods Administration (TGA),[3] and by Health Canada.[4] Telix’s miniaturised surgical gamma probe, SENSEI®, for minimally invasive and robotic-assisted surgery, has attained a marketing authorisation in the U.S., having been registered with the FDA and has attained a Conformité Européenne (CE) Mark for use in the European Economic Area for the intra-operative detection of sentinel lymph nodes (SLNs). With the exception of Illuccix® and SENSEI® as noted above, no Telix product has received a marketing authorisation in any jurisdiction.
This announcement has been authorised for release by the Telix Pharmaceuticals Limited Disclosure Committee on behalf of the Board.
Legal Notices
The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to shares of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement. The information contained in this announcement is subject to change without notification.
This announcement may contain forward-looking statements that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “outlook”, “forecast” and “guidance”, or other similar words. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on the Company’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect the Company’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress and results of Telix’s preclinical and clinical studies, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enrol and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals, manufacturing activities and product marketing activities; the commercialisation of Telix’s product candidates, if or when they have been approved; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements. You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the ASX or on our website.
To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to publicly update or revise any forward-looking statements contained in this announcement, whether as a result of new information, future developments or a change in expectations or assumptions.
OSAKA, Japan, March 11, 2024 /PRNewswire/ — Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; “Ono”) today announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University (Cambridge, MA, USA; “Harvard“) aiming at validating novel therapeutic targets.
In this alliance, as part of our ongoing open innovation initiative to collaborate with external partners, the request for proposals will be for research projects focused on the validation of novel therapeutic targets from labs across Harvard University in Ono’s priority research areas of oncology, immunology, neurology, and specialty with high unmet medical needs. Working together with Harvard’s Office of Technology Development (OTD), Ono will support and fund research projects that are jointly selected. With the combined expertise and resources of both Ono and Harvard, this strategic alliance will promote our innovative drug discovery efforts.
Ono has been dedicated to the drug discovery and development of innovative drugs, focusing on priority areas of oncology, immunology, neurology, and specialty areas to fulfill unmet medical needs. Ono has generated a number of innovative medicines, by proactively promoting “open innovation” by working with external partners. Through our unique drug discovery approach based on open innovation, we will be committed to creating innovative drugs.
“We are pleased to work together with Harvard University, a leading institution developing cutting-edge technologies and advancing research through strategic alliances such as this one,” stated Toichi Takino, Senior Executive Officer / Executive Director, Discovery & Research at Ono Pharmaceutical. “Our alliance with Harvard University leverages the complementary strengths to accelerate the validation of novel therapeutic targets that would lead to the discovery of new drugs. We will continue to work hard to deliver innovative drugs for patients with unmet medical needs.”
“Harvard’s alliance with Ono underscores the university’s commitment to advancing our understanding and treatment of some of today’s most pressing health issues,” stated Vivian Berlin, Executive Director, Harvard Medical School in Harvard’s Office of Technology Development. “The alliance will support research projects that pave the way for a future where complex diseases are better understood and more effectively treated.”
“Strategic alliances bring together academic discovery with industrial capabilities,” stated Isaac Kohlberg, Senior Associate Provost and Chief Technology Development Officer at Harvard University. “Not only accelerating the translation of groundbreaking discoveries into tangible innovations but also enriching academic research with real-world applications.”
About Harvard University’s Office of Technology Development
Harvard’s Office of Technology Development (OTD) promotes the public good by fostering innovation and translating new inventions made at Harvard University into useful products that are available and beneficial to society. Our integrated approach to technology development comprises sponsored research and corporate alliances, intellectual property management, and technology commercialization through venture creation and licensing. More than 100 startups have launched to commercialize Harvard technologies in the past 5 years. To further bridge the academic-industry development gap, Harvard OTD manages the Blavatnik Biomedical Accelerator and jointly oversees the Harvard Gridand the Climate and Sustainability Translational Fund. For more information, please visit https://otd.harvard.edu.
Sensodyne has expanded its fastest growing Advanced range of Sensitivity and Gum with its latest innovation that helps relieve Sensitivity, restore Gum Health & strengthen Enamel.
All-year round NEW awareness campaign to educate consumers on the importance of dealing with Enamel erosion and Gum problems – the two leading causes of tooth Sensitivity – in collaboration with healthcare professionals, social creators, and influencers.
With the aim to unite Malaysians under the banner of a #BetterOralCareNation, Sensodyne offers one month of free dental check-ups – to be conducted across 1000 clinics in Malaysia in collaboration with the Malaysian Dental Association.
KUALA LUMPUR, Malaysia, March 11, 2024 /PRNewswire/ — This World Oral Health Day, Sensodyne, the #1 Sensitivity Toothpaste brand in Malaysia*, launched Sensodyne Sensitivity Gum & Enamel, a clinically proven, ground-breaking innovation with a specialized triple mode of action formula that provides long-lasting sensitivity relief, helps restores gum health, and strengthens enamel in two weeks. Its innovative Micro Foam technology effectively delivers the active ingredient (Stannous Fluoride) in hard-to-reach areas between teeth and along the gumline.
Sensodyne introduces NEW Triple Action Formula: ‘Sensitivity Gum & Enamel’
Oral health problems are considered to be largely preventable through effective oral hygiene, yet their prevalence remains high. In Malaysia, 94% of Malaysian adults have gum problems, 71% suffer from tooth sensitivity, and nearly 46% experience yellowing of teeth, which may be due to the loss of enamel, according to a 2021 Kantar study. These findings highlight a significant consumer need for solutions addressing a range of oral health concerns in Malaysia.
Sensitivity in teeth is primarily caused by gum issues and enamel erosion. Enamel is the outer most protective layer of the tooth which may weaken with time due to acids in common food and beverages, whereas gum problems stem from plaque bacteria accumulation.
“While many Malaysians face tooth sensitivity, gum problems, and enamel issues, solutions exist”, says Bryan Wong, General Manager, Malaysia, Singapore and Brunei (MSB), Haleon. Bryan added, “Nine out of tens adults are at risk of enamel loss due to acidic foods, yet so many people are unaware of the effect it can have on our teeth. At Haleon, we believe that healthy teeth should not be an exclusive privilege. Through the introduction of Sensodyne Sensitivity Gum & Enamel and the #BetterOralCareNation campaign, we aim to inspire Malaysians to prioritize their oral health by presenting accessible solutions.”
Sensodyne is continuing its movement of #BetterOralCareNation to raise oral health awareness across Malaysia and motivate Malaysians to prioritize their oral health for healthier gums and teeth. The campaign includes a captivating television commercial, eye-catching outdoor advertising, engaging on-ground activities, and informative content across Sensodyne Malaysia’s website, social media channels, and traditional media platforms. By collaborating with healthcare professionals, social media creators, and influencers, Sensodyne aims to deliver channel-relevant reliable information.
The campaign officially launched on 1st March, with the first event taking place on 7th March at Sunway Velocity Mall in Kuala Lumpur, with free dental check-up (sensitivity, gum and enamel tests). As part of the engagement activities, the popular #BetterOralCareNation anthem is brought back on social media to inspire Malaysians to improve their oral health awareness and practices.
Sensodyne Sensitivity Gum & Enamel toothpaste can be found in pharmacies, dental clinics, minimarkets, supermarkets, and hypermarkets across Malaysia.
Haleon (LSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon’s product portfolio spans five major categories – Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands – such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum – are built on trusted science, innovation and deep human understanding.
Haleon (LSE: HLN) is a global leader in consumer health, with brands trusted by millions of consumers globally. Haleon Malaysia employs over 500 people whose purpose is to deliver better everyday health with humanity. With market leading positions in oral care, pain relief, and wellness, we work closely with pharmacists, physicians, and retailers to increase awareness of everyday health issues and concerns and emphasise the importance of self-care. Haleon’s Hulu Kelang site in Kuala Lumpur also supplies countries around the world with high quality and innovative consumer healthcare products, such as Panadol, ENO and Polident.
“Whether you think you can, or you think you can’t – you’re right.” ~ Henry Ford
The blogging team came across this insightful article on the Integrity Property Investment website and we have gained their approval to publish it here so our readers can enjoy and learn from it too!
The worst thing you can do is start out convincing yourself that you cannot succeed. What I’ve learned over the years that has served me well is that we are all allocated the same resources: a human body with its brain and its brawn, and 168 hours of time per week. How we use these resources is the difference between those who are successful and those who are not.
Success has nothing to do with the circumstances you were born into, nothing to do with race, religion and cultural values. It has everything to do with the conscious decisions you make on how you spend your time and the actions you choose to take. Psychology and mindset are critical in this – you must believe in yourself and that you are capable of achieving success. It really is that simple.
If another human being has done it, you can do it too!
Close the gap between their knowledge and yours by finding out how they achieved success and what knowledge they have, then educate yourself and take action – do the same things they did to get to that level of success. It has never been easier to educate yourself than now with access to the internet and all the online resources it provides.
You simply need to stop making excuses and copping out. Put down the gossip magazines, stop playing computer games and turn off the mindless TV shows and start investing in yourself and your own education by searching online for videos, books and courses. Start taking action! Do something now so that you can have the life you truly dream about for yourself and your family, whether that’s the family you have now or the family you plan on having in the future.
Your retirement savings / pension / super is not enough
Learn to think like the wealthy 1%
The fluctuations of property markets
Understanding property finance
Growing your property portfolio from scratch
Finding the right investment property
Calculating the costs of acquiring and holding a property
Property contracts
Risk management
Personal finance fundamentals
Paying off your house faster
The levels of wisdom about debt
Building your team of experts
Starting your property investment journey
Most people keep their money in a metaphorical bucket. It’s usually a bucket with a few holes in it. Wealth Through Property will show you how to fix the holes and create a variety of money buckets to serve different purposes to grow your wealth. Real estate is a very expensive teacher if you make a mistake and do the wrong thing. Rather learn from the mistakes of others, let me show you how! ~ Daimien Patterson
For information on Defence Home Ownership Assistance Scheme, visit Integrity Property Investment’s website here: DHOAS
For information on The Home Purchase Assistance Scheme, visit integrity Property Investment website here: HPAS
Lights, camera, Oscars! The curtain is up on the 96th Academy Awards. As you read this, Hollywood’s biggest stars are gathering at the Dolby Theatre in Los Angeles, California to walk the Oscars red carpet. This year’s show has an earlier start time than usual, kicking off at 7 p.m. ET. The ceremony will see performances of all five of the original songs nominated this year, including a much-anticipated live performance of “I’m Just Ken” from Ryan Gosling. The list of presenters is — unsurprisingly — star-studded, including Zendaya, Nicolas Cage, Jamie Lee Curtis, America Ferrera, Brendan Fraser, Ariana Grande, Ryan Gosling, Matthew McConaughey, Michelle Yeoh and Al Pacino.
There are ten films up for arguably the biggest category of the evening: Best Picture. Christopher Nolan’s Oppenheimerleads the category with 13 nominations. Barbie, Poor Things, American Fiction, The Holdovers, Killers of the Flower Moon, Maestro, Past Lives, The Zone of Interest and Anatomy of a Fall round out the category.
Are you ready to tune in? Here’s what you need to know about watching the 2024 Oscars this year — with or without cable.
The Oscars will be held on Sunday, Mar. 10 (tonight!).
What time are the Oscars 2024?
The 2024 Oscars will have an earlier start time, beginning an hour earlier than usual, at 7 p.m. ET.
What time is the Oscars red carpet?
E! is covering the Oscars red carpet this year, starting at just 4 p.m. ET, giving you three hours of lead up to the Academy Awards tonight. You can also catch red carpet coverage on ABC, or via the AP’s free red carpet livestream:
What channel are the Oscars on?
The 96th Academy Awards will air on ABC, which you may have access to through cable or a live TV antenna. Don’t have access to ABC? You can stream the channel live with the help of a live TV streaming service like Fubo, DirecTV Stream, YouTube TV (all of which offer free trial periods) and more. Here’s what we recommend for how to watch the Academy Awards without cable.
Where to watch the Oscars 2024:
Where to stream the Oscars:
Oscars livestream 2024:
If you have cable, you can login with your provider and watch the Oscars livestream on ABC’s website and on the ABC app.
Who is hosting the Oscars this year?
Jimmy Kimmel will once again host the Academy Awards this year.
Who is performing at the Oscars tonight?
Ryan Gosling will perform “I’m Just Ken” at the Oscars this year. (Jordan Strauss/Invision/AP, File)
All five of this year’s Academy Award-nominated original songs will be performed at the Oscars this year. Jon Batiste, Becky G, Billie Eilish and Finneas O’Connell, Scott George and the Osage Singers, and — finally confirmed — Ryan Gosling and Mark Ronson.
Who is presenting at the 2024 Oscars?
The list of confirmed Oscars presenters includes Zendaya, Emily Blunt, Cynthia Erivo, America Ferrera, Ryan Gosling, Ariana Grande, Anya Taylor-Joy, Nicolas Cage, Jamie Lee Curtis, Brendan Fraser, Matthew McConaughey, Michelle Yeoh, Al Pacino, Michelle Pfeiffer, Mahershala Ali, Jessica Lange, Ke Huy Quan, Bad Bunny, Chris Hemsworth, Dwayne Johnson, Michael Keaton, Regina King, Jennifer Lawrence, Kate McKinnon, Rita Moreno, John Mulaney, Catherine O’Hara, Octavia Spencer, Ramy Youssef and Sam Rockwell.Live18 updates
Vanessa Hudgens has an announcement…
Vanessa Hudgens arrives at the Oscars on Sunday, March 10, 2024, at the Dolby Theatre in Los Angeles. (AP Photo/Ashley Landis)
Vanessa Hudgens announced her pregnancy while co-hosting ABC’s Countdown to Oscars: On the Red Carpet Live!
